Polyclonal Crypt Genesis and Development of Familial Small Intestinal Neuroendocrine Tumors

Gastroenterology

Volumn 151, Issue 1, 2016, Pages 140-151

  Sei, Yoshitatsu ^a   Feng, Jianying ^a   Zhao, Xilin ^a   Forbes, Joanne ^a   Tang, Derek ^a   Nagashima, Kunio ^b   Hanson, Jeffrey ^c   Quezado, Martha M ^c   Hughes, Marybeth S ^c   Wank, Stephen A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Gene Expression; Malignancy; Small Intestine

Indexed keywords

BMI1 PROTEIN; G PROTEIN COUPLED RECEPTOR; HOPX PROTEIN; LGR5 PROTEIN; MITOCHONDRIAL DNA; RNA; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; BMI1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; HOP PROTEIN, HUMAN; LGR5 PROTEIN, HUMAN; TPH1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PATIENT; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; ENTEROCHROMAFFIN CELL; FAMILIAL CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINAL STEM CELL; INTESTINE CRYPT; JEJUNUM; MOUSE; NEUROENDOCRINE TUMOR; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE MUCOSA; SMALL INTESTINE TUMOR; TISSUE SECTION; CYTOLOGY; GENETICS; ILEUM TUMOR; JEJUNUM TUMOR; METABOLISM; MULTIGENE FAMILY; SMALL INTESTINE; STEM CELL;

CARCINOGENESIS; ENTEROCHROMAFFIN CELLS; HOMEODOMAIN PROTEINS; HUMANS; ILEAL NEOPLASMS; IN SITU HYBRIDIZATION; INTESTINE, SMALL; JEJUNAL NEOPLASMS; MULTIGENE FAMILY; NEUROENDOCRINE TUMORS; POLYCOMB REPRESSIVE COMPLEX 1; RECEPTORS, G-PROTEIN-COUPLED; STEM CELLS; TRYPTOPHAN HYDROXYLASE; TUMOR SUPPRESSOR PROTEINS;

EID: 84990043603     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.03.007     Document Type: Article

References (34)

1. 1 Nilsson, O., Profiling of ileal carcinoids. Neuroendocrinology 97 (2013), 7–18.
2. 2 Cunningham, J.L., Janson, E.T., The biological hallmarks of ileal carcinoids. Eur J Clin Invest 41 (2011), 1353–1360.
3. 3 Lembeck, F., [The detection of 5-hydroxytryptamine in carcinoid metastases]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol, 222, 1954, 235.
4. 4 Lechago, J., Neuroendocrine cells of the gut and their disorders. Monogr Pathol, 1990, 181–219.
5. 5 Barker, N., Ridgway, R.A., van Es, J.H., et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457 (2009), 608–611.
6. 6 Humphries, A., Wright, N.A., Colonic crypt organization and tumorigenesis. Nat Rev Cancer 8 (2008), 415–424.
7. 7 Sangiorgi, E., Capecchi, M.R., Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 40 (2008), 915–920.
8. 8 Mills, J.C., Sansom, O.J., Reserve stem cells: differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tract. Sci Signal, 8, 2015, re8.
9. 9 Barker, N., van Es, J.H., Kuipers, J., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449 (2007), 1003–1007.
10. 10 Cheng, H., Leblond, C.P., Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types. Am J Anat 141 (1974), 537–561.
11. 11 Tian, H., Biehs, B., Warming, S., et al. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 478 (2011), 255–259.
12. 12 Yan, K.S., Chia, L.A., Li, X., et al. The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc Natl Acad Sci U S A 109 (2012), 466–471.
13. 13 Potten, C.S., Kovacs, L., Hamilton, E., Continuous labelling studies on mouse skin and intestine. Cell Tissue Kinet 7 (1974), 271–283.
14. 14 Takeda, N., Jain, R., LeBoeuf, M.R., et al. Interconversion between intestinal stem cell populations in distinct niches. Science 334 (2011), 1420–1424.
15. 15 May, R., Sureban, S.M., Hoang, N., et al. Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively. Stem Cells 27 (2009), 2571–2579.
16. 16 Powell, A.E., Wang, Y., Li, Y., et al. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 149 (2012), 146–158.
17. 17 Basak, O., van de Born, M., Korving, J., et al. Mapping early fate determination in Lgr5+ crypt stem cells using a novel Ki67-RFP allele. EMBO J 33 (2014), 2057–2068.
18. 18 Sei, Y., Lu, X., Liou, A., et al. A stem cell marker-expressing subset of enteroendocrine cells resides at the crypt base in the small intestine. Am J Physiol Gastrointest Liver Physiol 300 (2011), G345–G356.
19. 19 Schonhoff, S.E., Giel-Moloney, M., Leiter, A.B., Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and non-endocrine cell types. Dev Biol 270 (2004), 443–454.
20. 20 Van Landeghem, L., Santoro, M.A., Krebs, A.E., et al. Activation of two distinct Sox9-EGFP-expressing intestinal stem cell populations during crypt regeneration after irradiation. Am J Physiol Gastrointest Liver Physiol 302 (2012), G1111–G1132.
21. 21 van Es, J.H., Sato, T., van de Wetering, M., et al. Dll1+ secretory progenitor cells revert to stem cells upon crypt damage. Nat Cell Biol 14 (2012), 1099–1104.
22. 22 Buczacki, S.J., Zecchini, H.I., Nicholson, A.M., et al. Intestinal label-retaining cells are secretory precursors expressing Lgr5. Nature 495 (2013), 65–69.
23. 23 Sei, Y., Zhao, X., Forbes, J., et al. A hereditary form of small intestinal carcinoid associated with a germline mutation in inositol polyphosphate multikinase. Gastroenterology 149 (2015), 67–78.
24. 24 Lundqvist, M., Wilander, E., A study of the histopathogenesis of carcinoid tumors of the small intestine and appendix. Cancer 60 (1987), 201–206.
25. 25 Moyana, T.N., Satkunam, N., A comparative immunohistochemical study of jejunoileal and appendiceal carcinoids. Implications for histogenesis and pathogenesis. Cancer 70 (1992), 1081–1088.
26. 26 Wright, N.A., Stem cell identification—in vivo lineage analysis versus in vitro isolation and clonal expansion. J Pathol 227 (2012), 255–266.
27. 27 Taylor, R.W., Barron, M.J., Borthwick, G.M., et al. Mitochondrial DNA mutations in human colonic crypt stem cells. J Clin Invest 112 (2003), 1351–1360.
28. 28 Lopez-Garcia, C., Klein, A.M., Simons, B.D., et al. Intestinal stem cell replacement follows a pattern of neutral drift. Science 330 (2010), 822–825.
29. 29 Snippert, H.J., van der Flier, L.G., Sato, T., et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143 (2010), 134–144.
30. 30 Greaves, L.C., Preston, S.L., Tadrous, P.J., et al. Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proc Natl Acad Sci U S A 103 (2006), 714–719.
31. 31 Dotto, G.P., Multifocal epithelial tumors and field cancerization: stroma as a primary determinant. J Clin Invest 124 (2014), 1446–1453.
32. 32 Melo, S.A., Sugimoto, H., O'Connell, J.T., et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell 26 (2014), 707–721.
33. 33 Thirlwell, C., Will, O.C., Domingo, E., et al. Clonality assessment and clonal ordering of individual neoplastic crypts shows polyclonality of colorectal adenomas. Gastroenterology 138 (2010), 1441–1454 1454 e1−e7.
34. 34 Thliveris, A.T., Schwefel, B., Clipson, L., et al. Transformation of epithelial cells through recruitment leads to polyclonal intestinal tumors. Proc Natl Acad Sci U S A 110 (2013), 11523–11528.